miR-27b-5p targets RAB27A to regulate exosome secretion and migration of pancreatic cancer cells Authors: Mengxiang Huang, Jie Ji, Ronghua Wang, Yan Kong, Dandan Jin, Junpeng Zhao, Tong Wu, Xuebing Xu, Xudong Xie, Yujie Jiao, Haiou Yan, Mingbing Xiao, Xiaogang Hu Published: 2026 ABSTRACT AbstractBackgroundExosomes are the key mediators of intercellular communication within the tumor microenvironment. Pancreatic cancer (PC) exhibits an abnormal increase in exosome secretion, and this abnormal secretion is closely associated with the invasive migration and metastatic progression of PC. Although the role of exosomes in PC metastasis has been confirmed, the precise molecular mechanism regulating this process remains unclear. This study aims to explore the regulatory mechanism of the exosome secretion cascade and its correlation with malignant migration in PC.MethodsBy comparing the serum miRNA profiles of PC patients with those of healthy controls, the key inhibitory factor microRNA-27b-5p (miR-27b-5p) was identified. After verifying its direct targeting of RAB27A, overexpression of miR-27b-5p and RAB27A rescue experiments were conducted in PC cells. Combined with the detection of intracellular multivesicular bodies (MVBs), the mechanism by which this axis regulates exosome secretion and PC metastasis was explored.ResultsIn vitro experiments demonstrated that miR-27b-5p, which plays a crucial regulatory role, was significantly downregulated in PC. Additionally, it significantly inhibited exosome secretion and migration ability of PC cells both in vivo and in vitro. Through biological analysis and luciferase reporter experiments, it was confirmed that miR-27b-5p directly targets RAB27A. Notably, functional experiments in PC cells indicated that overexpression of miR-27b-5p inhibited the expression level of RAB27A, exosome secretion ability, and the metastatic potential of cancer cells. Finally, a RAB27A rescue experiment was conducted to verify that overexpression of RAB27A counteracted the inhibitory effect of miR-27b-5p overexpression on PC exosome secretion.ConclusionsThis study reveals a novel molecular mechanism: miR-27b-5p directly targets RAB27A to suppress PC cell migration. This regulatory axis may contribute to exosome-related metastatic phenotypes of PC.Keywords: MicroRNA-27b-5p (miR-27b-5p), exosome secretion, RAB27A, pancreatic cancer (PC), cell migration Highlight box Key findings • MicroRNA-27b-5p (miR-27b-5p) is significantly downregulated in the serum, cancer tissues, and pancreatic cancer (PC) cells of patients with PC. This miRNA directly targets RAB27A, inhibiting the transport of multivesicular bodies (MVBs) to the cell membrane, reducing the release of exosomes, thereby inhibiting the migration of PC cells, without affecting cell proliferation. Restoring RAB27A can reverse the inhibitory effect of miR-27b-5p on the secretion and migration of exosomes by PC cells. What is known and what is new? • Exosomes mediate communication within the tumor microenvironment and promote invasion and metastasis of PC; RAB27A is responsible for the fusion of MVB membranes and the release of exosomes; miR-27b-5p plays a tumor-suppressing role in various solid tumors, but there is no report on its regulation of exosome secretion in PC. • For the first time, the miR-27b-5p/RAB27A/exosome secretion regulatory axis has been confirmed to exist in PC. This clarifies a new molecular mechanism by which miRNAs regulate the release of tumor exosomes through targeting vesicle transport proteins. What is the implication, and what should change now? • This regulatory axis provides a novel molecular explanation for PC metastasis; serum miR-27b-5p is associated with distant metastasis and tumor-node-metastasis stage, and has the potential to serve as a liquid biopsy marker; strategies to inhibit PC metastasis mediated by exosomes can be developed by targeting this pathway. Introduction Pancreatic cancer (PC) is a malignant tumor that mainly originates from the pancreatic ductal epithelium (1). Owing to its high degree of invasiveness and ease of early metastasis, once it is diagnosed, it is usually at an advanced stage (2). In modern society, with the acceleration of life and changes in dietary habits, the incidence of PC, a common malignant tumor of the digestive system, is increasing annually worldwide (3). It is predicted that PC will become the second leading cause of cancer death worldwide by 2030 (4). Despite many advances in the treatment of PC, unfortunately, approximately 80% of patients with PC are diagnosed with delayed disease because of the lack of typical symptoms in the early stage, few patients can receive surgical treatment, and the 5-year survival rate is still significantly low (5). In recent years, many of studies focused on the treatment of PC, especially targeted therapy and immunotherapy, which provide more treatment options and possibilities for patients with PC (6,7). Therefore, we still need to further explore the specific molecular mechanism underlying the occurrence and development of PC and find effective therapeutic targets to improve patient prognosis. Exosomes are extracellular vesicles containing abundant biological signaling substances, with a diameter of 30–150 nm (8). Almost all cells can secrete these vesicles with a bilayer membrane structure (9). Exosomes are known to be endocytic from the cell membrane to form early endosomes, after which the early endosomes mature to form late endosomes and then invaginate again to develop into multivesicular bodies (MVBs) containing intraluminal vesicles (ILVs) (10,11). Finally, MVBs are transported to the cell membrane and fuse with them to release ILVs into the extracellular environment (12). Members of the RAB GTPase family participate in the entire biological process of exosomes, and different RAB proteins play related roles in different regions of the cell (13). Exosomes play an important role in intercellular communication, especially tumor-derived exosomes (TDEs) (14). TDEs frequently transfer oncogenic microRNAs (miRNAs) to cells by inducing epithelial-mesenchymal transition (EMT) and modulating the tumor microenvironment (TME), thereby promoting metastasis (15). Stem cell-derived exosomes carry therapeutic signaling molecules, inhibit apoptosis and stimulate angiogenesis in damaged tissues (16,17). Notably, tumor cell-derived exosomes participate in the formation of the TME before metastasis and promote the occurrence and development of tumors through immune escape (18). For example, in thyroid cancer, tumor-associated fibroblast-derived exosomes promote the malignant progression of thyroid cancer through immune escape (19). Investigators have also reported that colorectal cancer cell-derived exosomes can promote their migration and play a potential role in inducing colorectal cancer liver metastasis (20). In addition, studies have shown that the number of exosomes secreted by lung cancer cells is closely related to the degree of malignancy, which mainly promotes tumor progression by inducing angiogenesis and cell migration (21). Exosomes regulate the progression, drug resistance and immune escape of PC through multiple mechanisms (22,23). With increasing of research, the regulation of tumor exosome secretion has shown great potential and potential in tumor treatment (24). Earlier studies confirmed that, compared with other solid tumors, PC can release more exosomes (25,26). Exosomes derived from PC can mediate the metastasis of PC by inducing M2 polarization of tumor-associated macrophages, angiogenesis and EMT (27,28). The main problem that needs to be addressed in PC is its metastasis phenomenon, which is the primary cause of treatment failure and patient death (29). The aforementioned research confirmed that this complex process is regulated by cell communication within the TME. Moreover, as key carriers for intercellular information transmission, exosomes play a central role in reshaping the premetastatic TME and promoting the spread of PC (30,31). Therefore, exosomes have great potential in tumor treatment and are expected to provide better treatment opportunities for cancer patients. miRNAs are a unique class of noncoding RNAs present in eukaryotes (32). Its biological occurrence requires the cleavage of the primary transcript (pri-miRNA) by the nuclear Drosha-DGCR8 complex to generate the precursor (pre-miRNA), which is then transported to the cytoplasm by Exportin-5 (33,34). It is further cleaved by the Dicer enzyme to form mature double-stranded RNA, with one of the strands integrated into the RNA-induced silencing complex (RISC) (35,36). miRNAs can bind to the 3'-untranslated region (3'UTR) of their downstream target gene sequences and play a regulatory role at the posttranscriptional gene level in a variety of cancers (37,38). miRNAs are abnormally expressed in a variety of cancers and promote cancer progression by affecting the cell cycle, migration, and angiogenesis (31,39). In addition, miRNAs can also play a role by transmitting regulatory signals through extracellular vesicles (40,41). Previous studies have focused mainly on the effects of miRNAs carried by exosomes on the occurrence and development of tumors, but few studies have focused on whether miRNAs can directly regulate exosomes (42). Previous studies have shown that miR-27b-5p promotes the malignant progression of ovarian and gastric cancer by affecting cell migration (43,44). With respect to the role of miR-27b-5p in ovarian cancer, existing studies have confirmed its tumor suppressive function through multiple mechanisms (45). Another study showed that miR-27b binds to the 3’UTR of VE-cadherin mRNA, and its upregulation can reduce the expression of VE-cadherin, thereby inhibiting vasculogenic mimicry, migration and invasion of ovarian cancer cells (46). In gastric cancer, miR-27b (including miR-27b-5p) acts as a tumor suppressor rather than an oncogene (47). Moreover, another study verified that miR-27b can target VEGFC and that its overexpression inhibits the proliferation of gastric cancer cells and induces apoptosis, which also supports its tumor—suppressive role in gastric cancer (48). In hepatocellular carcinoma (HCC), miR-27b clearly exerts a tumor-suppressive effect and is closely related to patient prognosis (49,50). Liu et al. demonstrated that miR-27b is significantly downregulated in oral squamous cell carcinoma (OSCC) tissues and cells and that its overexpression can inhibit the proliferation of OSCC cells by targeting FZD7 and suppressing the activity of the Wnt signaling pathway (51,52). Moreover, in OSCC, the overexpression of miR-27b-5p was shown to have an antitumor effect by inhibiting cell proliferation (53). Although the role of miR-27b-5p in PC has been reported, whether and how it modulates tumor cell migration (a critical step for metastasis) via regulating intercellular communication remains unexplored. In this study, we evaluated the possible role of miR-27b-5p in PC metastasis by targeting RAB27A to regulate PC exosome secretion. We found that miR-27b-5p was downregulated in PC and that upregulation of miR-27b-5p promoted PC cell migration ability and significantly reduced the secretion of exosomes in vitro and in vivo. In addition, we demonstrated that miR-27b-5p affects PC metastasis by regulating exosome secretion. When miR-27b-5p was overexpressed, RAB27A expression was significantly downregulated, and RAB27A was reported to target exosomes to the plasma membrane. We confirmed that miR-27b-5p directly targeted RAB27A via a dual-luciferase reporter assay. Restoring RAB27A expression partially offset the inhibitory effect of miR-27b-5p on exosome secretion. Our work elucidates a novel mechanism by which miR-27b-5p medulates PC cell migration via the “miR-27b-5p/RAB27A/exosome secretion” axis. This provides a potential target for interfering with exosome-mediated malignant phenotypes in PC. We present this article in accordance with the MDAR and ARRIVE reporting checklists (available at https://tcr.amegroups.com/article/view/10.21037/tcr-2026-0519/rc). Methods Cells and cell culture Human normal pancreatic ductal epithelial cells (hTERT-HPNE), human PC cell lines (PANC-1, CFPAC-1, BXPC-3, and HPAC) and HEK-293T cell lines were purchased from the BeNa Culture Collection. The hTERT-HPNE, PANC-1, HPAC and HEK-293T cell lines were cultured in DMEM (HyClone, Cytiva, USA) containing 10% fetal bovine serum (FBS) (Gibco, Grand Island, NY, USA) and 1% penicillin-streptomycin (New Cell & Molecular Biotech Co., Ltd., Suzhou, China). The CFPAC-1 cell line was cultured in IMDM (Gibco) supplemented with 20% FBS and 1% penicillin-streptomycin. The BxPC-3 cell line was cultured in RPMI 1640 (HyClone) supplemented with 10% FBS and 1% penicillin-streptomycin. The above cell lines were cultured in an incubator at 37 ℃ with 5% CO2. Clinical samples A total of 24 pairs of PC tissues and adjacent tissues were obtained from patients diagnosed with PC, who were admitted to the Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University between January 2022 and December 2025. All the samples were snap frozen in liquid nitrogen and stored at −80 ℃. Serum samples from PC patients and healthy subjects were collected from the Affiliated Hospital of Nantong University. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. The study was approved by the Research Ethics Committee of Affiliated Hospital of Nantong University (No. 2023-K212-01). Informed consent was obtained from the patients before the study. GeneChipTM miRNA 4.0 array Serum samples were collected from 3 patients with PC and 3 healthy controls at the Affiliated Hospital of Nantong University. GeneChem (Shanghai, China) was commissioned to perform miRNA 4.0 chip analysis. The raw microarray data with qualified quality control data were screened, and the significantly different miRNAs were screened according to a |fold change| >1.5. Gene Ontology (GO) enrichment analysis According to the fold change, the top 20 miRNAs with the greatest difference were selected, and the target genes were predicted via three databases (TargetScan, microRNA.org, and miRDB) Finally, GO annotation and enrichment analysis were performed on the predicted target genes. Animal experiments All the mice were purchased from the Laboratory Animal Center of Nantong University. All animal experiments were performed under a project license (No. S20220208-006) granted by the Animal Research Committee of Nantong University, in compliance with the guidelines and standards of National Institutes of Health (NIH) and China for the care and use of animals. Five-week-old male BALB/c nude mice were randomly divided into two groups at 21–23 ℃ and 40–60% humidity, with five mice in each group. Male BALB/c nude mice were used to reduce potential variability associated with sex hormone fluctuations, particularly because this in vivo experiment focused on circulating TDE secretion and serum exosomal markers. Mice of the same sex were used in all groups to minimize sex-related biological variability. The mice had ad libitum access to irradiated food and sterilized water. PC cells [2×106 cells dissolved in 100 µL of phosphate-buffered saline (PBS)] were injected into the armpit of the right dermis of each mouse. The right axillary subcutaneous region was selected because it provides a relatively loose subcutaneous space suitable for stable tumor establishment, allows convenient external observation and measurement of tumor growth, and causes relatively limited interference with animal movement, feeding, and grooming. The same injection site was used in all mice to minimize site-related variability. This subcutaneous xenograft model was used as a controlled in vivo tumor-bearing system to assess whether miR-27b-5p affects the release of TDEs into the circulation. It was not intended to fully reproduce the orthotopic pancreatic TME or the entire exosome-mediated metastatic process. After 45 days, the mice were sacrificed, and the tumor weights were measured, while the blood of the mice was collected for subsequent experiments. Cell transfection When the fusion rate of the PC cells reached 70%, the miR-27b-5p overexpression lentiviral vector (MIAOLING BIOLOGY, Wuhan, China) was used to infect them for 48 h, and stably transfected cell lines were obtained after one week of drug screening. The RAB27A overexpression lentiviral vector (GeneChem) and the miR-27b-5p overexpressing lentiviral vector were cotransfected into PC cells (PANC-1). Quantitative real-time polymerase chain reaction (qRT-PCR) Total RNA was extracted from cells and tissues via TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Total RNA was extracted from the serum via the SPARKeasy Total RNA Extraction Kit for Frozen Whole Blood (SparkJade, Jinan, China) according to the manufacturer’s instructions. Total RNA (2 µg) was reverse transcribed to cDNA with HiScript III RT SuperMix for qPCR (+gDNA wiper) (Vazyme, Nanjing, China) or a miRNA 1st Strand cDNA Synthesis Kit (stem-loop) (Vazyme). qRT-PCR was performed using ChamQ Blue Universal SYBR qPCR Master Mix (Vazyme). The primers for the target genes or miRNAs were synthesized by Sangon Biotech (Shanghai, China) or RIB BIO (Guangzhou, China). We used the following primers: GAPDH forward: 5'-CAGGAGGCATTGCTGATGAT-3', GAPDH reverse: 5'-GAAGGCTGGGGCTCATTT-3'; RAB2B forward: 5'-ATCCAGCAGGGTTTATTTGATGTCC-3', RAB2B reverse: 5'-GTTCAGCAGCAGCCAGAGTTG-3'; RAB5 forward: 5'-ACCACCACCGCCATAGATACAC-3', RAB5 reverse: 5'-ACCTGAGACCGCAGCAAGC-3'; RAB7A forward: 5'-GGAGTTGGCGGCTTGGAGAG-3', RAB7A reverse: 5'-CGGAGGACAGAAGCGAGAAGG-3'; RAB9A forward: 5'-GGACACGGCAGGTCAGGAG-3', RAB9A reverse: 5'-GTAAGCAGGCAGCAGTCAGAAC-3'; RAB11A forward: 5'-CGTGGAGCTGTAGGTGCCTTATTG-3', RAB11A reverse: 5'-TCTGTAGGAACTGCCCTGAGATGAC-3'; RAB35 forward: 5'-TCTTCTCACCGACTCTCCACTTG-3', RAB35 reverse: 5'-CTCCACAGCACCCTCCTTCC-3'; RAB27A forward: 5'-TCTGGACCTGATAATGAAGCGAATG-3', RAB27A reverse: 5'-CTTAACTGATCCGTAGAGGCATGAC-3'; RAB27B forward: 5'-TGGGTTGTGGCTGGGTATTCC-3', RAB27B reverse: 5'-CTTGTTCCTGCTCACTTTCCTTCC-3'; GAPDH was used as the internal control for mRNA detection, and U6 was used as the internal control for miRNA detection. The relative expression levels were calculated using the 2−ΔCt method, where ΔCt = Ct-target − Ct-reference. No additional normalization to a calibrator sample was performed unless otherwise stated. Cell viability and colony formation PC cells were seeded in 96-well plates at a density of 5,000 cells/well. After 12 h, 100 µL of serum-free medium containing 10% CCK-8 reagent (Vazyme) was added daily at fixed time points. After incubation at 37 ℃ for 2 h, the absorbance at 450 nm was measured with a microplate reader (Thermo Fisher Scientific, Waltham, MA, USA). For the colony formation assay, PC cells were seeded in 6-well plates at a density of 3,000 cells/well, and the cells were cultured for 2 weeks. When clonal colonies appeared under the microscope (Olympus, Tokyo, Japan), the culture medium was discarded, and the colonies were fixed with 4% paraformaldehyde (Servicebio, Wuhan, China) for 30 min and stained with crystal violet (Beyotime, Shanghai, China) for 30 min. Colonies were counted for the entire field, and each result was analyzed in duplicate three times. EdU cell proliferation assay PC cells at 90% confluence were collected, diluted tenfold, seeded in 24-well plates and cultured overnight. The experiments were performed according to the instructions of the BeyoClickTM EdU-555 (Beyotime) kit. Finally, immunofluorescence imaging was performed via a Zeiss microscope (Axio Vert5). The images were analyzed quantitatively via ImageJ software. Wound-healing assay PC cells were cultured in 6-well plates, and when the cells reached approximately 70% to 80% confluence, a sterile 100 µL pipette tip was used to scratch the bottom monolayer of cells in the Petri dish via a ruler. After three washes with PBS (Servicebio) at certain intervals (0, 24 h), the scratched area was imaged under a microscope (Nikon, Tokyo, Japan). The cell migration rate (%) = was calculated as follows: (0 h width of scratch − 24 h width of scratch)/0 h width of scratch × 100%. Transwell migration assay A total of 600 µL of DMEM/IMDM containing 10% FBS was added to the lower chamber of a 24-well plate, followed by the addition of the upper chamber polycarbonate (Corning, NY, USA) filter membrane (pore size: The PC cells were suspended in serum-free medium at a density of 2×104 cells/well and seeded in the upper chamber). After 48 h of culture, the cells on the bottom surface of the chamber were fixed with 4% paraformaldehyde for 30 min and stained with crystal violet for 30 min, and the remaining cells in the chamber were carefully removed with a cotton swab. Images were taken and counted under a microscope (Nikon) with a ×4 field of view. Exosome extraction For cell exosome extraction, when the cell density reached approximately 80%, the medium was removed, the cells were washed three times with PBS, serum-free medium was added, the cell supernatant was collected, and the cells were counted after further culture for 48 h. The supernatant was then subjected to gradient centrifugation at 4 ℃, first at 300×g for 15 min to remove dead cells, then at 3,000×g for 30 min to remove cell debris, and finally at 16,500×g for 1 h to remove large extracellular vesicles (EVs). The centrifuged supernatant was filtered through a 0.22 µm filter (Millipore, Billerica, MA, USA). The filtered supernatant was then centrifuged at 150,000×g (Beckman Coulter, Tokyo, USA) for 2 h at 4 ℃. The exosome precipitate was washed in precooled PBS and centrifuged again at 150,000×g (HITACHI, Brea, CA, Japan) at 4 ℃ for 2 h. Finally, 100 µL of precooled PBS was added to resuspend the exosome precipitate. After mouse blood was collected, the serum was obtained via centrifugation at 3,000 rpm for 15 min at 4 ℃. Mouse serum exosomes were extracted according to the ExoQuick Exosome Isolation Reagent Kit (SBI, Palo Alto, CA, USA). Transmission electron microscopy (TEM) Exosomes were suspended and placed on a 200-mesh copper grid for 10 min, stained with 20 µL of 0.2 M phosphotungstic acid for 2 min at room temperature, and then dried under infrared light. The final analysis was performed via TEM at 120 kV. Determination of the exosome protein concentration A BCA protein detection kit (Beyotime) was used to prepare the working solution according to the instructions of the kit. The standard solution and the processed exosome samples were added to a 96-well plate, and each sample was add to three wells. The protein concentration in the sample was calculated from a standard curve by measuring its absorbance at 562 nm. Nanoparticle tracking analysis (NTA) NTA can directly track the number and size of exosomes. Exosomes were diluted in nanoparticle-free PBS, resuspended, and injected into a ZetaView nanoparticle tracking analyzer (Particle Metrix). It tracks the random Brownian motion of exosomes and finally uses the Stokes-Einstein equation to calculate the number and size of exosomes. Uptake of exosomes Small sterile glass discs were placed in 24-well plates, in which PC cells were uniformly seeded at an appropriate density and cultured overnight. The extracted exosomes were incubated with PKH67 dye (Sigma-Aldrich, ST. Louis, MO, USA) in the dark at room temperature for 5 min. After centrifugation at 120,000×g for 2 h, the dye was removed, and the stained exosomes were subsequently incubated with the remaining cells for 24 h. The cells were then fixed with 4% polyoformaldehyde (Servicebio) for 30 min at room temperature, after which the nuclei were stained with DAPI (Beyotime), and images were taken under a Nikon A1r confocal microscope. Western blot Cellular and exosomal proteins were separated via sodium dodecyl sulfide-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore). The membranes were blocked in TBST (19 mM Tris base, 2.7 mM KCl, 137 mM NaCl, and 0.1% Tween-20) in 5% nonfat milk for 1.5 h and incubated with primary antibodies overnight at 4 ℃. The cells were then incubated with a horseradish peroxidase-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA) for 1.5 h at room temperature. Finally, enhanced chemiluminescence (ECL) reagent (New Cell & Molecular Biotech) was used to detect protein expression. The following antibodies were used: anti-CD63 (anti-CD63 with human) (ab59479, 1:1,000; Abcam, Cambridge, UK), anti-CD81 (ab79559, 1:500; Abcam), anti-TSG101 (ab125011, 1:1,000; Abcam), anti-Calnexin (ab22595, 1:1,000; Abcam), anti-GAPDH (60004-1-1 g, 1:5,000; Proteintech), anti-RAB27A (ab55667, 1:1,000; Abcam), anti-RAB5 (ab18211, 1:1,000; Abcam), anti-RAB7 (55469-1-AP, 1:1,000; Proteintech), and anti-FLAG (66008-4-1 g, 1:1,000; Proteintech). Immunofluorescence Sterile glass discs were placed in 24-well plates. The cells were collected when the degree of cell confluence in the culture dish reached 90%, diluted 10 times, spread to 24-well plates, and cultured in an incubator overnight. The next day, the 24-well plates were removed and fixed with 4% formaldehyde for 30 min at room temperature, followed by permeabilization with 0.8% Triton X-100 (PBS configuration) for 20min and then blocked with 5% BSA (PBS configuration) for 2 h at room temperature and incubated with primary antibodies prepared with 5% BSA (1:200) overnight at 4 ℃. The primary antibody was discarded after rewarming for 30 min at room temperature. A fluorescently labeled secondary antibody (1:500) was prepared with 5% BSA and incubated with the sample for 2 h at room temperature in the dark. Finally, the plates were incubated in the dark for 5 min with DAPI (Beyotime), carefully removed, and attached on the front side to a slide containing 4 µL of anti-fluorescence quenching mounting solution (Beyotime). Immunofluorescence imaging was performed via a Nikon A1r confocal microscope. The images were quantified by ImageJ software. The following antibodies were used: anti-CD63 (ab59479, 1:200; Abcam), anti-ALIX (ab117600, 1:200; Abcam), anti-RAB27A (ab55667,1:200; Abcam), anti-RAB5 (ab18211, 1:200; Abcam) and anti-RAB7A (55469-1-AP, 1:200; Proteintech). Dual-luciferase reporter assay We commissioned Hanbio Biotechnology Co. Ltd. (Shanghai, China) to design and construct the required plasmids. The plasmids were gently mixed with Lipofectamine 2000 (Invitrogen), added to HEK-293T cells infected with miRNA lentivirus and cultured for 48 h. The cells were treated according to the instructions of the dual luciferase reporter kit (RG027, Beyotime), the full wavelength microplate reader (Thermo Fisher) was turned on, and firefly luciferase detection reagent and Renilla luciferase detection reagent were added to detect the corresponding light units according to the instructions. Statistical analysis All statistical analyses were performed via GraphPad Prism 9, and the results are presented as the mean ± standard deviations. Each experiment was repeated independently. A t-test was used for comparisons between two groups, and one-way analysis of variance was used for comparison between multiple groups. A P value <0.05 was considered to indicate statistical significance. Results Levels of miR-27b-5p in PC We the first performed GeneChipTM miRNA 4.0 array analysis using serum samples from 3 healthy controls and 3PC patients as an exploratory screening step. We found that 27 miRNAs were downregulated in the serum of PC patients compared with healthy controls and that 9 miRNAs were upregulated (|fold change| >1.5) (Figure 1A). We subsequently selected significantly downregulated candidate miRNAs for further validation in PC cell lines. Among these candidates, miR-27b-5p showed the most prominent difference and was therefore selected for subsequent functional analyses (Figures S1,S2). Moreover, we collected the serum of 43 healthy people and 51 patients with PC for further verification. Consistent with previous results, the expression of miR-27b-5p was downregulated in the serum of patients with PC (Figure 1B). We subsequently analyzed the correlation between the serum miR-27b-5p level and clinicopathological parameters in 43 patients with PC and reported that the miR-27b-5p level was correlated with distant metastasis and tumor-node-metastasis (TNM) stage but not with sex, age, tumor size, location, degree of differentiation or lymph node metastasis (Table 1). In addition, RNA was extracted from the cancer and paracarcinoma tissues of 24 patients with PC for real-time quantitative PCR, and a low level of miR-27b-5p was also detected in patients with PC (Figure 1C). Finally, we detected the level of miR-27b-5p in normal pancreatic ductal epithelial cells and four PC cells lines and again found that the level of miR-27b-5p was low in cancer cells, especially in PANC-1 and CFPAC-1 cells; thus, subsequent experiments were carried out in these two cell lines (Figure 1D). Levels of miR-27b-5p in pancreatic cancer. (A) Heatmap showing differential levels of miRNAs in the serum of three pancreatic cancer patients and three healthy controls. (B) The level of miR-27b-5p in the serum of 51 healthy subjects and 43 patients with pancreatic cancer was detected via qRT-PCR. (C) qRT-PCR was used to measure the level of miR-27b-5p in 24 pairs of pancreatic cancer tissues and adjacent tissues. (D) miR-27b-5p levels in hTERT-HPNE, BxPC-3, HPAC, PANC-1, and CFPAC-1 cell lines. **, P<0.01. N, node; qRT-PCR, quantitative real-time polymerase chain reaction; T, tumor. Table 1Correlation between miR-27b-5p level and clinicopathological parameters in 43 pancreatic cancer patientsParametersTotal, nmiR-27b-5p level, nPearson χ2P valueHighLowSex0.2900.86 Male241212 Female19109Age (years)0.8030.37 <601385 ≥60301416Site0.6170.43 Head/neck19118 Body/tail241113Size (cm)0.0430.83 <41587 ≥4281414Differentiation4.1840.12 Well/middle18108 Poor19712 Unknown651TNM stage13.0840.02* I1174 II20146 III817 IV404Lymphatic metastasis1.1630.55 Yes1275 No311516Distant metastasis7.9270.005* Yes12210 No312011Pearson χ2 test was used for statistical analysis. *, P<0.05 was considered statistically significant. TNM, tumor-node-metastasis. Correlation between miR-27b-5p level and clinicopathological parameters in 43 pancreatic cancer patients Pearson χ2 test was used for statistical analysis. *, P<0.05 was considered statistically significant. TNM, tumor-node-metastasis. miR-27b-5p can significantly inhibit the migration of PC cells but has no effect on proliferation Because miR-27b-5p was expressed at a low level in two PC cell lines, PANC-1 and CFPAC-1, we established stable overexpression of miR-27b-5p in these two types of PC cells, and the transfection efficiency was verified by real-time quantitative PCR (Figure 2A). To explore the effect of miR-27b-5p on the proliferation of PC cells, we performed counting kit-8 (Figure 2B), colony formation (Figure 2C) and EdU cell proliferation (Figure 2D,2E) experiments. The upregulation of miR-27b-5p had no effect on the proliferation of PC cells. Furthermore, we investigated whether miR-27b-5p affects the migration of PC cells, and the results revealed that upregulation of miR-27b-5p expression significantly reduces the migration distance of cells (Figure 2F). Transwell assays also revealed that upregulation of miR-27b-5p could inhibit the migration of PC cells (Figure 2G). Thus, we found that the miR-27b-5p level was negatively correlated with cell migration ability. These results suggest that miR-27b-5p does not affect the proliferation of PC cells but significantly affects their ability to migrate. miR-27b-5p can significantly inhibit the migration of pancreatic cancer cells but has no effect on proliferation. (A) qRT-PCR verified the overexpression efficiency of miR-27b-5p in PANC-1 and CFPAC-1 cells. (B) CCK8 assay was used to detect the effect of miR-27b-5p overexpression on the proliferation of PANC-1 and CFPAC-1 cells. (C) The effect of miR-27b-5p overexpression on the proliferation of PANC-1 and CFPAC-1 cells was detected via colony formation assay, and the number of cell clones in different groups was quantified. (D) EdU cell proliferation assay was used to detect the effect of miR-27b-5p overexpression on the proliferation of PANC-1 and CFPAC-1 cells. EdU fluorescence staining of proliferating cells. Representative images were taken with a ×10 objective lens. (E) Quantitative analysis of the proportion (%) of EdU-positive cells among total cells in different groups. (F) The effect of miR-27b-5p overexpression on the migration of PANC-1 and CFPAC-1 cells at 24 h was detected via cell scratch assay, the scratch area of different groups of cells was quantified, and the area difference obtained at 0 h and 24 h was normalized to that at 0 h. (G)Transwell migration assays were used to detect the effect of miR-27b-5p overexpression on the migration of PANC-1 and CFPAC-1 cells, and the proportion of the cell migration area in the different groups was quantified. Migrated cells were fixed and stained with 0.1% crystal violet. Representative images were captured with a ×4 objective lens. ns, no significance; **, P<0.01; ***, P<0.001. CCK8, cell counting kit-8; qRT-PCR, quantitative real-time polymerase chain reaction. miR-27b-5p inhibits PANC-1 cell migration via RAB27A-dependent impairment of exosome secretion and MVB accumulation Given that PC secretes more exosomes than other tumors do and that exosomes play a role in tumor metastasis, we collected the cell supernatants of the control group and the miR-27b-5p overexpressing group from the same number of cells. The exosomes in the cell supernatant were extracted via gradient centrifugation and characterized via electron microscopy. We observed that upregulation of miR-27b-5p did not change the size or shape of the exosomes secreted by the cells (Figure 3A). We then detected the total exosomal protein content via a BCA assay and found that, compared with that in the same number of control cells, the content of exosomal protein secreted by the miR-27b-5p overexpressing group was significantly lower (Figure 3B). Similarly, NTA revealed that the number of particles secreted by cells in the miR-27b-5p overexpression group was reduced, but the size of the particles did not change (Figure 3C). We subsequently validated the results via Western blotting to detect common exosome markers, including CD63 and CD81. Consistent with the previous results, the overexpression of miR-27b-5p led to a reduction in CD63 and CD81 in the exosomes (Figure 3D and Figure S3A). To determine the role of miR-27b-5p in exosome secretion, we will further study it in nude mice. The cells in the control group and miR-27b-5p overexpression group were injected into the armpit of nude mice on one side to establish an ectopic transplantation tumor model. Forty-five days after the mice were sacrificed, the volume and weight of the tumors in the miR-27b-5p overexpression group did not differ from those in the control group (Figure 3E). We then extracted mouse serum exosomes and performed Western blotting with a specific antibody that recognized only human CD63 to detect the number of human TDEs in mouse serum. As expected, the level of human CD63 exosome protein in the control mice serum was significantly higher than that in the miR-27b-5p overexpression group (Figure 3F). These results suggested that miR-27b-5p reduced the release of TDEs into the circulation in the subcutaneous xenograft model. Next, to explore whether the effect of miR-27b-5p exosome secretion affects PC metastasis, we stimulated the PC cell line PANC-1, which has low metastatic potential, with exosomes extracted from different groups of cell culture supernatants. First, we observed that the stained exosomes were taken up by PANC-1 cells (Figure 3G). Second, we stimulated PC cells with the same number of exosomes and the same number of exosomes, and through scratch experiments (Figure 3H,3I) and Transwell experiments (Figure 3J,3K), we found that in the same number of cells, the overexpression of miR-27b-5p reduced the number of exosomes secreted by the cells, and its ability to migrate to PANC-1 cells was significantly lower than that of the control group. However, if an equal number of exosomes were used to stimulate PANC-1 cells, the results revealed that there was little effect on their migration, which ruled out the influence the of exosome content. Therefore, we suggest that miR-27b-5p regulates PC cell migration mainly by modulating exosome secretion. miR-27b-5p inhibits PANC-1 cell migration via RAB27A-dependent impairment of exosome secretion and MVB accumulation. (A) Exosomes extracted from the culture supernatants of PANC-1 and CFPAC-1 cells from different groups were observed and photographed via transmission electron microscopy. (B) BCA protein quantification assay was used to determine the total exosomal protein concentration of the exosomes extracted from the culture supernatants of different groups of PANC-1 and CFPAC-1 cells. (C) Nanoparticle tracking analysis of exosomes extracted from the supernatants of PANC-1 and CFPAC-1 cells from different groups was performed and standardized according to cell number. The number of exosome particles in three independent experiments was also quantified and normalized according to the number of cells. (D) The levels of exosome marker proteins extracted from the supernatants of equal numbers of PANC-1 and CFPAC-1 cells from different groups were detected by Western blot, and the levels of exosome marker proteins in three independent experiments were quantified. (E) PANC-1 cells from the Ctrl-OE group and the miR-27b-5p-OE group were subcutaneously injected into 5-week-old male nude mice (5 mice in each group). The mice were sacrificed after 45 days, and tumor images of the mouse loads were collected. The tumor weights of the Ctrl-OE and miR-27b-5p-OE groups were quantified. The tumor volume of the mice was measured every 5 days. (F) Exosome levels in the serum of two different groups of nude mice were detected by Western blot. Quantification of serum exosome levels in different groups of mice. Cell nuclei were counterstained with DAPI (blue). Representative fluorescence images were captured with a ×40 objective lens. (G) Fluorescence microscopy revealed that PANC-1 cells actively internalized exosomes extracted from the supernatants of CFPAC-1 cells in different groups, which were subsequently stained. Scale bar, 10 μm. The migration ability of PANC-1 cells was examined by (H) Transwell migration assays and (I) cell scratch assays after stimulation with exosomes extracted from the supernatants of different groups of CFPAC-1 cells. The number of exosomes in the different groups was standardized to equal numbers of cells and equal numbers of exosomes. (J) Quantitative analysis of PANC-1 cell migration after stimulation with exosomes from different cell sources. (K) Quantitative analysis of the scratch area of PANC-1 cells stimulated with different groups of cell-derived exosomes, and the difference in the area obtained at 0 h and 24 h was normalized to that at 0 h. ns, no significance; **, P<0.01; ***, P<0.001; ****, P<0.0001. MVB, multivesicular body; PBS, phosphate-buffered saline. The intracellular aggregation of MVBs caused by miR-27b-5p may be related to the RAB family Previous studies have shown that miR-27b-5p plays a role in exosome secretion by PC cells. To further understand the mechanism by which miR-27b-5p overexpression impairs exosome secretion by PC cells, we analyzed the number of MVBs in cells via Western blot experiments and immunofluorescence technology. Interestingly, although the secretion of exosomes was significantly reduced after miR-27b-5p overexpression, the number of intracellular MVBs was significantly greater than that in the control group, suggesting that miR-27b-5p overexpression may lead to abnormal accumulation of MVBs in cells (Figure 4A-4C and Figure S3B). To more clearly understand the specific mechanism by which miR-27b-5p regulates exosome secretion by PC cells, we performed GO enrichment analysis of its downstream genes according to the GeneChipTM miRNA 4.0 chip and found that they were highly correlated with GTPase enzyme activity (Figure 4D). The Rab family is closely related to exosome biogenesis and plays a key role in intracellular vesicle trafficking. Therefore, we screened PC cells (PANC-1 and CFPAC-1) and found that RAB27A was the most significantly inhibited by miR-27b-5p overexpression as detected by real-time quantitative PCR (Figure 4E). According to reports that RAB27A plays a key role in the last step of exosome biogenesis, it can transport MVBs to the plasma membrane, thereby promoting the release of exosomes. We wondered whether the downregulation of RAB27A after miR-27b-5p overexpression led to the failure of MVBs to be secreted and the accumulation of MVBS in the cells. The intracellular aggregation of MVBs caused by miR-27b-5p may be related to the RAB family. (A,B) Exosomal protein levels after the overexpression of miR-27b-5p in PANC-1 and CFPAC-1 cells were measured via Western blot and cellular immunofluorescence. Scale bar, 10 μm. (C) Quantification of the number of CD63-positive or AliX-positive particles per cell after the overexpression of miR-27b-5p in PANC-1 and CFPAC-1 cells. Each point represents the number of CD63-positive or AliX-positive particles in a single cell. (D) GO enrichment analysis of downstream genes was performed according to the GeneChipTM miRNA 4.0 chip. (E) qRT-PCR was used to detect changes in the levels of downstream target genes after the overexpression of miR-27b-5p in PANC-1 and CFPAC-1 cells. ns, no significance; *, P<0.05; **, P<0.01; ***, P<0.001. BP, biological process; CC, cellular component; FDR, false discovery rate; GO, Gene Ontology; MF, molecular function; MVB, multivesicular body; qRT-PCR, quantitative real-time polymerase chain reaction. miR-27b-5p regulates exosome secretion by PC cells by targeting RAB27A To better understand the causes of MVB aggregation, we examined the levels of several classical RAB proteins involved in exosome biogenesis via Western blotting and immunofluorescence. RAB5 is associated with early endosomes, and RAB7 can target MVBs to lysosomes for degradation. The results revealed that the change in the miR-27b-5p level did not affect the expression levels of RAB5 and RAB7. However, consistent with the previous results, RAB27A was significantly inhibited after miR-27b-5p overexpression (Figure 5A,5B and Figure S3C). Moreover, bioinformatics analysis revealed that different sites in the 3’-UTRs of RAB27A mRNA and miR-27b-5p had complementary base sequences (Figure 5C). Then, we constructed plasmids with the above sequences for dual-luciferase reporter assays, and the results revealed that miR-27b-5p directly targeted RAB27A (Figure 5D). To further explore the specific molecular mechanism by which miR-27b-5p regulates exosome secretion, RAB27A was overexpressed in PANC-1 cells in the control group and the miR-27b-5p overexpression group, and the transfection efficiency was verified by Western blotting and qRT-PCR (Figure 5E,5F). Moreover, because miR-27b-5p directly targeted RAB27A, changes in RAB27A levels did not affect miR-27-5p levels (Figure 5G). To verify that miR-27b-5p regulates exosome secretion through RAB27A, we performed rescue experiments. The results of the BCA protein quantification (Figure 5H), NTA (Figure 5I) and Western blot (Figure 5J) experiments revealed that the total amount of exosomal protein secreted by PC cells after the overexpression of miR-27b-5p was significantly lower than that in the control group without changing the level of RAB27A. However, after RAB27A was overexpressed in the miR-27b-5p overexpression group, the exosomal protein level increased. These results indicated that RAB27A overexpression partially reversed the reduction in exosome secretion caused by miR-27b-5p overexpression. In conclusion, miR-27b-5p regulated the secretion of exosomes from PC cells by targeting RAB27A. miR-27b-5p regulates exosome secretion by pancreatic cancer cells by targeting RAB27A. (A) The protein levels of RAB5, RAB7 and RAB27A after the overexpression of miR-27b-5p in PANC-1 and CFPAC-1 cells were detected via Western blot. (B) Cellular immunofluorescence showing the levels of RAB5, RAB7 and RAB27A in PANC-1 and CFPAC-1 cells overexpressing miR-27b-5p, and the fluorescence intensity of each cell line was quantified. Scale bar, 10 μm. (C) Nucleotide sequence and site of miR-27b-5p complementary to the RAB27A 3’-UTR. Mut: a mutation containing 6 bases in the target region of miR-27b-5p. (D) Luciferase assays confirmed that miR-27b-5p binds to the wild-type 3’-UTR sequence of RAB27A. (E) The efficiency of RAB27A overexpression in different cells was detected via Western blot. (F,G) The efficiency of RAB27A overexpression and miR-27b-5p overexpression in different cells was examined via qRT-PCR. (H) BCA protein quantification assay was used to determine the total exosomal protein concentration of the exosomes extracted from the culture supernatants of the PANC-1 cells in the different groups. (I) Nanoparticle tracking analysis was used to detect exosomes extracted from the supernatants of PANC-1 cells in different groups, which were normalized according to the number of cells. (J) The levels of exosome marker proteins extracted from the supernatants of PANC-1 cells in different groups were detected by Western blot, and the levels of exosome marker proteins in three independent experiments were quantified. ns, no significance; **, P<0.01; ***, P<0.001; ****, P<0.0001. 3’-UTR, 3’-untranslated region; qRT-PCR, quantitative real-time polymerase chain reaction. Discussion PC is one of the most difficult cancers to conquer because of its complex TME and high mortality (54). The 5-year survival rate is less than 10%, and the median survival time is less than 6 months, which seriously threatens the life of patients (55). The causes of the high mortality rate of PC are as long as it is difficult to detect in the early stage, it progresses rapidly, there are few treatment options, and it has a poor prognosis (56,57). Previous studies have shown that EMT, hypoxia and glycolysis can affect the malignant progression of PC (58,59). Exosomes play important roles in the TME and intercellular communication. There is increasing evidence that exosomes are involved in tumor proliferation, angiogenesis and metastasis (60). Therefore, targeted regulation of exosome secretion has potential value for tumor therapy, especially in PC, which secretes many exosomes. Although research on exosomes in tumors has made breakthroughs, most studies still focus on the effects of exosome contents on tumor progression. Notably, few studies have investigated the mechanisms related to the biological process of exosomes, and new antitumor drugs that can target the secretion of exosomes need to be further studied. In this study, we found that miR-27b-5p was downregulated in PC and investigated its role in regulating exosome secretion and PC cell migration. We first performed GeneChipTM miRNA 4.0 array analysis on the serum of patients with PC and healthy controls and determined that miR-27b-5p was significantly reduced in patients with PC. One limitation of the initial miRNA microarray analysis is the small sample size and the presence of inter-individual variability in serum miRNA profiles. Therefore, the microarray result was used only for candidate screening, and the selection of miR-27b-5p was further supported by validation in a larger serum cohort, paired clinical tissues, PC cell lines, and clinicopathological correlation analysis. Therefore, we detected the serum level of miR-27b-5p in patients with the PC and analyzed its correlation with clinicopathological parameters of patients with PC. The results revealed that a decrease in the serum miR-27b-5p level in patients with PC was associated with distant metastasis and TNM stage. miR-27b-5p has potential clinical value in the diagnosis of PC. In addition, the overexpression of miR-27b-5p significantly inhibited the migration ability of PC cells but had little effect on proliferation. NTA, BCA and Western blotting confirmed that miR-27b-5p overexpression inhibited the secretion of exosomes from PC cells. Although the subcutaneous xenograft model allowed us to evaluate circulating TDEs under relatively controlled tumor-burden conditions, it cannot fully recapitulate the orthotopic pancreatic TME or spontaneous metastatic cascade. Therefore, this model mainly supports the role of miR-27b-5p in regulating TDE release in vivo. Future studies using orthotopic PC models or metastasis models are needed to further determine how the miR-27b-5p/RAB27A axis affects exosome-mediated tumor progression and metastasis in a more physiologically relevant setting. Exosome biogenesis is a complex multistep process that mainly includes the formation of early exosomes, the maturation of late exosomes, the transport of multivesolar bodies, and the fusion of plasma membranes (61). GO enrichment analysis of downstream target genes revealed that they were highly related to the RAB GTPase family. Notably, RAB family members, including RAB2, RAB5, RAB7, RAB9, RAB11, RAB27A, RAB27B and RAB35, are involved in exosome biogenesis and release (9,62,63). Our results revealed that RAB27A expression was significantly downregulated after the overexpression of miR-27b-5p, and the dual luciferase reporter assay confirmed that miR-27b-5p directly targeted RAB27A. In addition, RAB27A overexpression partially reversed the miR-27b-5p-induced reduction in exosome secretion by PC cells. miR-27b-5p modulates PC cell migration by targeting RAB27A to regulate exosome secretion, which may further influence tumor metastatic progression (Figure 6). miR-27b-5p targets RAB27A to participate in the secretion of exosomes from pancreatic cancer cells. Donor cells form early endosomes through endocytosis, and RAB5 is involved in this process. Early endosomes are further endocytosed to form late endosomes, which develop and mature to form multivesicular bodies. RAB7A can transport MVBs to lysosomes for degradation. In this study, miR-27b-5p directly targeted RAB27A to transport MVBs to the plasma membrane and promote exosome secretion; thus, more exosomes were taken up by recipient cells, ultimately promoting pancreatic cancer metastasis. This figure was drawn by Figdraw. MVB, multivesicular body. In fact, TDEs carrying differentially expressed miRNAs have been shown to affect malignant tumor progression through the TME and intercellular communication (64,65). However, the mechanism by which miRNAs directly regulate tumor exosome secretion is still unclear. Studies have shown that miR-124-3p regulates cell invasion and migration by targeting RAB27A in lung cancer (66). Researchers have reported that miR-192 affects exosome secretion by regulating RAB proteins (67). At present, the specific molecular mechanism by which miRNAs affect exosome secretion is still not fully understood, and further research is needed. The role of exosome secretion induced by miR-27b-5p in PC metastasis provides potential clinical value for identifying exosome secretion-related tumor treatment targets. Conclusions In summary, our research, through miRNA microarray analysis, revealed a new regulatory axis in PC: miR-27b-5p, which is abnormally downregulated in PC tissues and directly and specifically targets RAB27A. This work revealed for the first time that miR-27b-5p is a key regulatory factor for exosome secretion in PC cells, providing unprecedented insights into the molecular mechanism of cell communication in this highly malignant tumor. Mechanistically, the overexpression of miR-27b-5p significantly inhibits the expression of RAB27A in PC cells, leading to the accumulation of MVB within the cells and ultimately significantly inhibiting the release of exosomes, which are key mediators of PC progression and metastasis. Overall, our findings indicate that miR-27b-5p exerts suppresses PC cell migration via the RAB27A-exosome pathway, suggesting a potential inhibitory role in PC metastatic phenotypes., providing a new paradigm shift in understanding exosome generation in PC. In addition to elucidating a previously unknown regulatory mechanism, this study revealed that miR-27b-5p is a highly promising therapeutic target and offers a new strategy for intercepting exosome-mediated oncogenic signals in PC treatment. Supplementary The article’s supplementary files as Acknowledgments None. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. The study was approved by the Research Ethics Committee of Affiliated Hospital of Nantong University (No. 2023-K212-01). Informed consent was obtained from the patients before the study. All animal experiments were performed under a project license (No. S20220208-006) granted by the Animal Research Committee of Nantong University, in compliance with the guidelines and standards of National Institutes of Health (NIH) and China for the care and use of animals. Footnotes Reporting Checklist: The authors have completed the MDAR and ARRIVE reporting checklists. Available at https://tcr.amegroups.com/article/view/10.21037/tcr-2026-0519/rc Funding: This work was supported by the National Natural Science Foundation of China (Nos. 82272624 and 82471851), the Natural Science Foundation of Jiangsu Province (No. BK20251835), the China University Industry-Academia-Research Innovation Fund of the Ministry of Education (No. 2025XH033), the Key Research and Development Project of Nantong City, China (Special Project for Prospective Technology Innovation) (No. GZ2024007), the Open Research Projects from the PRC Ministry of Education Engineering Research Center of Intelligent Technology for Healthcare (No. JYBJNKY-2024-06), the Nantong City Social Livelihood Science and Technology Program (No. JCZ2025009), the Jianghai Talent Cultivation Project of Nantong City (No. 2025-6-2), the China Postdoctoral Science Foundation (No. 2024M751536), and the Postgraduate Research and Practice Innovation Program of Jiangsu Province (Nos. KYCX25_3797, and KYCX25_3789). Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-2026-0519/coif). The authors have no conflicts of interest to declare. Data Sharing Statement Available at https://tcr.amegroups.com/article/view/10.21037/tcr-2026-0519/dss References Available at https://tcr.amegroups.com/article/view/10.21037/tcr-2026-0519/prf Supplementary Materials The article’s supplementary files as Data Availability Statement Available at https://tcr.amegroups.com/article/view/10.21037/tcr-2026-0519/dss